Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

Saved in:
Bibliographic Details
Main Authors: Katie Foug, Stephanie L. Skala, Erica Stein, Kevin Reynolds, Jean Siedel, Shitanshu Uppal
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Gynecologic Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925000499
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850146634386636800
author Katie Foug
Stephanie L. Skala
Erica Stein
Kevin Reynolds
Jean Siedel
Shitanshu Uppal
author_facet Katie Foug
Stephanie L. Skala
Erica Stein
Kevin Reynolds
Jean Siedel
Shitanshu Uppal
author_sort Katie Foug
collection DOAJ
format Article
id doaj-art-d359236c740b41dba8abb51397c10bbf
institution OA Journals
issn 2352-5789
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Gynecologic Oncology Reports
spelling doaj-art-d359236c740b41dba8abb51397c10bbf2025-08-20T02:27:47ZengElsevierGynecologic Oncology Reports2352-57892025-04-015810172410.1016/j.gore.2025.101724Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case reportKatie Foug0Stephanie L. Skala1Erica Stein2Kevin Reynolds3Jean Siedel4Shitanshu Uppal5University of Michigan, School of Medicine, Ann Arbor, MI, United States; Corresponding author at: 1217 Island Drive Apt 104, Ann Arbor, MI 48105, United States.Michigan Medicine, Department of Pathology, Ann Arbor, MI, United StatesMichigan Medicine, Department of Radiology, Ann Arbor, MI, United StatesMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United StatesMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United StatesMichigan Medicine, Department of Gynecology Oncology, Ann Arbor, MI, United Stateshttp://www.sciencedirect.com/science/article/pii/S2352578925000499PARP inhibitorUterine adenosarcomaSomatic BRCA mutationRecurrent disease
spellingShingle Katie Foug
Stephanie L. Skala
Erica Stein
Kevin Reynolds
Jean Siedel
Shitanshu Uppal
Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
Gynecologic Oncology Reports
PARP inhibitor
Uterine adenosarcoma
Somatic BRCA mutation
Recurrent disease
title Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
title_full Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
title_fullStr Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
title_full_unstemmed Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
title_short Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report
title_sort four year recurrence free survival in metastatic uterine adenosarcoma with somatic brca2 mutation on olaparib therapy a case report
topic PARP inhibitor
Uterine adenosarcoma
Somatic BRCA mutation
Recurrent disease
url http://www.sciencedirect.com/science/article/pii/S2352578925000499
work_keys_str_mv AT katiefoug fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport
AT stephanielskala fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport
AT ericastein fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport
AT kevinreynolds fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport
AT jeansiedel fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport
AT shitanshuuppal fouryearrecurrencefreesurvivalinmetastaticuterineadenosarcomawithsomaticbrca2mutationonolaparibtherapyacasereport